Livermore

First Light Asset Management, LLC

SEC CIK
0001600004

Holdings, Q2 2026

Positions as of Jun 30, 2026, filed Aug 14, 2026.SEC

Positions
31
−4 vs. Q1 2026
Total value
$1.65B
+$529.4M (+47.4%) vs. Q1 2026

Compare with Q1 2026: new, added, reduced and sold out

Positions

Long positions only. Changes compare share counts with Q1 2026.

First Light Asset Management, LLC holdings in Q2 2026
SecurityClassSharesValue% of portfolioChange in sharesActionHistory
NEONEOGENOMICS INCCOM NEW12,279,523$179.16M10.89%+2,549,545+26.2%AddedView
SIBNSI-BONE INCCOM8,127,985$132.65M8.06%+2,774,795+51.8%AddedView
AXGNAXOGEN INCCOM2,748,361$126.95M7.72%−1,254,407−31.3%ReducedView
APOGEE THERAPEUTICS INC03770N101COM930,289$123.48M7.50%+353,605+61.3%Added–
PVLAPALVELLA THERAPEUTICS INC NECOM771,901$117.96M7.17%−208,857−21.3%ReducedView
TWSTTWIST BIOSCIENCE CORPCOM727,933$74.89M4.55%−150,915−17.2%ReducedView
ELVNENLIVEN THERAPEUTICS INCCOM1,360,750$69.06M4.20%+1,158,883+574.1%AddedView
GHGUARDANT HEALTH INCCOM441,586$66.25M4.03%+161,287+57.5%AddedView
MASS908 DEVICES INCCOM6,282,804$54.66M3.32%+210,241+3.5%AddedView
AMLXAMYLYX PHARMACEUTICALS INCCOM3,023,256$54.3M3.30%−167,389−5.2%ReducedView
WGSGENEDX HOLDINGS CORPCOM CL A783,923$53.82M3.27%+540,996+222.7%AddedView
SLPSIMULATIONS PLUS INCCOM2,792,677$51.13M3.11%+159,854+6.1%AddedView
TNDMTANDEM DIABETES CARE INCCOM NEW3,383,553$51.06M3.10%+2,068,838+157.4%AddedView
CRINETICS PHARMACEUTICALS IN22663K107COM1,360,866$50.92M3.10%+271,196+24.9%Added–
NPCENEUROPACE INCCOM2,861,167$45.46M2.76%+401,201+16.3%AddedView
EWTXEDGEWISE THERAPEUTICS INCCOM1,095,171$44.5M2.70%+93,325+9.3%AddedView
ANABANAPTYSBIO INCCOM582,004$39.29M2.39%+16,573+2.9%AddedView
TRVITREVI THERAPEUTICS INCCOM2,097,215$39.11M2.38%+2,097,215NewView
SEPNSEPTERNA INCCOM963,260$32.26M1.96%+230,400+31.4%AddedView
TLSITRISALUS LIFE SCIENCES INCCOM6,552,491$29.81M1.81%+1,485,664+29.3%AddedView
TECXTECTONIC THERAPEUTIC INCCOM800,726$27.52M1.67%+152,983+23.6%AddedView
HCATHEALTH CATALYST INCCOM12,810,861$25.49M1.55%−67,839−0.5%ReducedView
BFLYBUTTERFLY NETWORK INCCOM CL A2,642,404$22.25M1.35%−17,763−0.7%ReducedView
ESTAESTABLISHMENT LABS HLDGS INCCOM246,577$21.16M1.29%−61,161−19.9%ReducedView
PCVXVAXCYTE INCCOM345,157$20.06M1.22%+203,373+143.4%AddedView
IRTCIRHYTHM TECHNOLOGIES INCCOM167,092$19.88M1.21%−1,024−0.6%ReducedView
OMCLOMNICELL COMCOM452,324$18.78M1.14%−37,522−7.7%ReducedView
ATRCATRICURE INCCOM567,838$15.89M0.97%−161,683−22.2%ReducedView
KRMDKORU MEDICAL SYSTEMS INCCOM3,387,902$14.23M0.86%−380,478−10.1%ReducedView
TCMDTACTILE SYS TECHNOLOGY INCCOM462,562$13.78M0.84%+462,562NewView
RYTMRHYTHM PHARMACEUTICALS INCCOM85,765$9.52M0.58%−1,416−1.6%ReducedView

Sold out since Q1 2026 (6)

Positions held at the end of Q1 2026 that are no longer in this filing.

First Light Asset Management, LLC positions sold out since Q1 2026
SecurityClassShares, Q1 2026Value, Q1 2026% of portfolio, Q1 2026
CENTESSA PHARMACEUTICALS PLC152309100SPONSORED ADS1,560,991$62M5.56%
WVEWAVE LIFE SCIENCES LTDSHS1,843,968$13.37M1.20%
VERAVERA THERAPEUTICS INCCL A313,906$12.63M1.13%
MDXGMIMEDX GROUP INCCOM2,842,892$11.23M1.01%
SGPSPYGLASS PHARMA INCCOM SHS375,000$9.72M0.87%
ORGOORGANOGENESIS HLDGS INCCOM3,498,533$8.29M0.74%

13F filings by quarter

First Light Asset Management, LLC 13F filings by quarter
QuarterFiledPositionsTotal valueChangesFiling
Q2 2026Aug 14, 202631$1.65Bvs. Q1 2026SEC
Q1 2026May 15, 202635$1.12Bvs. Q4 2025SEC
Q4 2025Feb 17, 202633$1.31Bvs. Q3 2025SEC
Q3 2025Nov 14, 202541$1.06Bvs. Q2 2025SEC
Q2 2025Aug 14, 202538$771.31Mvs. Q1 2025SEC
Q1 2025May 15, 202537$875.71Mvs. Q4 2024SEC
Q4 2024Feb 14, 202536$1.05Bvs. Q3 2024SEC
Q3 2024Nov 14, 202438$1.2Bvs. Q2 2024SEC
Q2 2024Aug 14, 202444$1.14Bvs. Q1 2024SEC
Q1 2024May 15, 202450$1.31Bvs. Q4 2023SEC
Q4 2023Feb 14, 202475$1.24Bvs. Q3 2023SEC
Q3 2023Nov 14, 202375$1.05Bvs. Q2 2023SEC
Q2 2023Aug 14, 202379$1.28Bvs. Q1 2023SEC
Q1 2023May 15, 202374$1.11Bvs. Q4 2022SEC
Q4 2022Feb 14, 202374$1.08Bvs. Q3 2022SEC
Q3 2022Nov 14, 202271$988.11Mvs. Q2 2022SEC
Q2 2022Aug 12, 202271$859.41Mvs. Q1 2022SEC
Q1 2022May 13, 202275$1.13Bvs. Q4 2021SEC
Q4 2021Feb 14, 202279$1.4Bvs. Q3 2021SEC
Q3 2021Nov 12, 202183$1.52Bvs. Q2 2021SEC
Q2 2021Aug 13, 202179$1.67Bvs. Q1 2021SEC
Q1 2021May 17, 202177$1.51B–SEC